Systemic lupus erythematosus trials recruiting in New York

All Systemic lupus erythematosus trials nationally

Cities in New York

Recruiting trials in New York

• A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
  NCT07260877 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · New York: Fairport
• A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
  NCT06570798 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · New York: Great Neck, Hawthorne, New York, Rochester
• A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
  NCT06411249 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · New York: Brooklyn
• A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
  NCT06617325 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · New York: Brooklyn, Manhasset, New York, Syracuse
• Alnuctamab for Refractory SLE (LATTE Study)
  NCT07219563 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · New York: New York
• An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
  NCT05835310 · Phase: Phase 3 · Ages: 5 Years to 17 Years · Sex: All (male and female) · New York: New Hyde Park, New York, The Bronx, Valhalla
• Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
  NCT05799378 · Phase: Phase 3 · Ages: 55 Years and older · Sex: All (male and female) · New York: New York, The Bronx
• HEALTH Home Urinalysis Testing
  NCT07823478 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)
  NCT00198068 · Phase: Not specified · Ages: 18 Years to 45 Years · Sex: Female · New York: New York
• RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
  NCT06121297 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · New York: New York, Rochester
• Safety and Efficacy of ONT01 in Lupus
  NCT07107659 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: New York
• Safety of the Herpes Zoster Subunit Vaccine in Lupus
  NCT05559671 · Phase: Phase 4 · Ages: 18 Years to 90 Years · Sex: All (male and female) · New York: New York
• Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
  NCT03816345 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · New York: Mineola, New York